Invest with an experienced team who performs intensive research in an effort to beat the S&P 500.
The KNGS ETF invests in compounders: companies generating cash and reinvesting at a higher rate of return than the overall market.
The fund seeks to provide long-term capital growth; income is a secondary objective.
“A tiny U.S. hedge fund has just become the first to convert into an exchange-traded fund.”
We interview customers, competitors, and experts to understand exactly where our companies stand against the competition.
We offer access to Compound Kings® exclusively through the KNGS ETF to keep fees low and leverage the tax efficiency of an ETF.
With 16 years of investing and operating experience, Robert leads the research team in seeking to identify current and future compounders.
Join over a thousand investors who subscribe to our updates.